-Synephrine Ameliorates Alloxan-induced Diabetes Mellitus Through Inhibiting Oxidative Stress and Inflammation Suppressing the NF-kappa B and MAPK Pathways

Oxidative stress and inflammation play important roles in the development of diabetes mellitus. -Synephrine, the primary pharmacologically active protoalkaloid in species, has been popularly consumed as a dietary supplement for weight loss management. However, the effects of -synephrine on diabetes mellitus and the action mechanisms have not been clearly elucidated. In this study, the antioxidant effects of -synephrine were evaluated. The data showed that -synephrine treatment exhibited significant scavenging effects against DPPH, ABTS and OH radicals and showed high reducing power. Diabetic mice were developed by alloxan injection, followed by -synephrine administration to investigate its hypoglycemic effects . The results showed that -synephrine intervention significantly prevented alloxan-induced alteration in body weight, organ indexes, serum uric acid content and serum creatinine content. Meanwhile, -synephrine application significantly improved the lipid profiles, superoxide dismutase (SOD) and catalase (CAT) activities and glutathione (GSH) contents in the serum and kidneys of diabetic mice and reduced the malondialdehyde (MDA) content in the serum of diabetic mice. Further assays suggested that -synephrine treatment improved alloxan-induced decreases of glucose tolerance and insulin sensitivity. Also, -synephrine supplementation altered histopathological changes in the kidneys and interscapular brown adipose tissues in diabetic mice. In addition, -synephrine administration inhibited renal inflammation through suppressing tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-1β (IL-1β) gene expression levels, as well as CD45 expression levels. The anti-inflammatory effects were probably involved in the regulation of nuclear factor-κB (NF-κB) activation and mitogen-activated protein kinase (MAPK) phosphorylation. In conclusion, -synephrine application significantly ameliorated alloxan-induced diabetes mellitus by inhibiting oxidative stress suppressing the NF-κB and MAPK pathways.